ABAL Therapeutics

Student Entrepreneur

Shamus Roeder
MS, Biomedical Engineering, 2019

ABAL Therapeutics is designing software to lighten the burden on parents of children with autism by streamlining at-home ABA therapy exercises. Today, waitlists often exceed 18 months, costs can exceed $100K each year, and fewer than 30% of families have access to behavioral therapy. By delivering therapy through a digital platform, ABAL is making behavioral therapy a possibility for the more than 700,000 children affected by autism in the US.